Questcor Pharmaceuticals Inc (QCOR.OQ)
|Market Cap (Mil.):||$3,198.24|
|Shares Outstanding (Mil.):||60.77|
- Questcor Pharmaceuticals Inc said it was being investigated in multiple jurisdictions, in addition to an ongoing probe by the U.S. Attorney's office in Pennsylvania into its promotional practices, sending its shares down 10 percent.
Oct 29 - Questcor Pharmaceuticals Inc said it was being investigated in multiple jurisdictions, in addition to an ongoing probe by the U.S. Attorney's office in Pennsylvania into its promotional practices, sending its shares down 10 percent.
- Shares of Questcor Pharmaceuticals Inc rose as much as 26 percent to a life-high on Wednesday, after strong sales growth for Acthar allayed concerns that reimbursement issues would restrict sales for newer uses of the drug.
|Johnson & Johnson (JNJ.N)||$94.04||-0.40|
|Pfizer Inc. (PFE.N)||$31.65||+0.11|
|Novartis AG (NOVN.VX)||CHF69.80||-0.35|
|Merck & Co., Inc. (MRK.N)||$49.79||+0.40|
|Roche Holding Ltd. (ROG.VX)||CHF243.10||-3.10|
|Abbott Laboratories (ABT.N)||$37.36||-0.17|
|Bayer AG (BAYGn.DE)||€97.06||+1.05|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€73.70||-0.67|
|GlaxoSmithKline plc (GSK.L)||1,599.00p||-6.00|
Earnings vs. Estimates
Analyst Research Reports
Provider: S&P Capital IQ Factual Report
Provider: Pechala's Reports
Questcor Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.